RxDoctor Payments DataLook up a doctor →

Jeremy Baker, PA

Medical · Hartford, CTNPI 1295373785

Payments from drug & device makers

$7,664in general payments, 2019–2025

Across 369 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • AbbVie$715
  • Amgen$544
  • Lilly USA, LLC$457
  • AstraZeneca$424
  • Novo Nordisk$379
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$7,664100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott40$1,050
AbbVie(2 entities)55$715
Amgen(2 entities)26$544
Lilly USA, LLC18$457
AstraZeneca(2 entities)22$424
Novo Nordisk26$379
GSK12$276
Myriad Genetic Laboratories, Inc.13$204
Bayer8$192
Xeris Pharmaceuticals, Inc.9$183
Astellas Pharma US Inc7$164
Mallinckrodt Hospital Products Inc.7$164
Johnson & Johnson3$155
Corcept Therapeutics7$148
Dexcom, Inc.7$145
Boehringer Ingelheim6$142
Takeda Pharmaceuticals U.S.A., Inc.5$142
Exact Sciences4$133
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$130
Endo Pharmaceuticals Inc.7$123
Recordati_rare_diseases_inc.4$106
Insulet Corporation6$104
Sanofi-aventis U.S. LLC3$80
IBSA Pharma Inc.4$78
Radius Health, Inc.3$77
Pfizer3$73
Soleno Therapeutics, Inc.2$72
Mannkind Corporation2$72
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$70
Almatica Pharma LLC4$68
Progenics Pharmaceuticals, Inc.3$66
Merck3$64
Antares Pharma, Inc.2$55
Kyowa Kirin, Inc.3$52
Lexicon Pharmaceuticals, Inc.3$51
Amneal Pharmaceuticals LLC3$51
BETA Bionics, Inc.2$48
Otsuka America Pharmaceutical, Inc.2$47
Ascendis Pharma Endocrinology Inc2$44
Halozyme Inc2$42
Chiesi USA, Inc.2$38
Tolmar Pharmaceuticals, Inc.2$37
Actelion Pharmaceuticals US, Inc.2$36
Novartis1$33
Madrigal Pharmaceuticals1$25
Intra-sana Laboratories1$24
Neurocrine Biosciences, Inc.1$24
Ultragenyx Pharmaceutical Inc.1$23
Hollister Incorporated1$23
Mission Pharmacal Company1$23
Axsome Therapeutics, Inc.1$22
Phathom Pharmaceuticals, Inc.1$21
Olympus America Inc.1$19
Urogen Pharma, Inc.1$19
Biohaven Pharmaceuticals, Inc.1$19
Medtronic1$18
Verona Pharma, Inc.1$18
Rhythm Pharmaceuticals, Inc.1$18
Biogen1$17
Seqirus USA Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,664 in reported general payments places this provider in the 90th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut

Medicare billing

Part B allowed, 2024
$34,300
Medicare patients
131
Services billed
814

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide128$228,207
TrulicityDulaglutide102$169,377
JardianceEmpagliflozin72$98,763
MounjaroTirzepatide58$93,357
ProliaDenosumab53$91,371
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog49$87,962
JanuviaSitagliptin Phosphate51$75,563
FarxigaDapagliflozin Propanediol63$74,403
Tresiba Flextouch U-200Insulin Degludec51$72,042
Tresiba Flextouch U-100Insulin Degludec80$51,650
Humalog Kwikpen U-200Insulin Lispro21$37,381
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog33$36,781
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/717$36,259
Humalog Kwikpen U-100Insulin Lispro67$27,216
AveedTestosterone Undecanoate12$22,539

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humalog$457$274,356185 claims
Novo NordiskOzempic, Novolog$379$231,405139 claims
Boehringer IngelheimJardiance$142$98,76372 claims
AmgenProlia$544$91,37153 claims
MerckJanuvia, Janumet$64$85,36863 claims
AstraZenecaFarxiga$424$74,40363 claims
Endo Pharmaceuticals Inc.Aveed$123$22,53912 claims
Sanofi-aventis U.S. LLCLantus$80$2,55420 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$51$59999 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 592 medical providers in Connecticut.

Other medical in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →